New diarylsulfonamide inhibitors of Leishmania infantum amastigotes

New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...

Descripción completa

Detalles Bibliográficos
Autores principales: González, Myriam, Alcolea, Pedro José, Álvarez, Raquel, Medarde, Manuel, Larraga, Vicente, Peláez, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142021/
https://www.ncbi.nlm.nih.gov/pubmed/34015753
http://dx.doi.org/10.1016/j.ijpddr.2021.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142021/
https://www.ncbi.nlm.nih.gov/pubmed/34015753
http://dx.doi.org/10.1016/j.ijpddr.2021.02.006

Ejemplares similares